Elaia closes its third deep-tech seed fund at 134M

"The Paris-based venture capital firm has closed its DTS3 fund at €134 million, a 12 per cent overshoot that reflects both strong LP appetite for European deep tech and the firm's long-cultivated position as the preferred backer of research-born startups."

"DTS3, the third generation of Elaia's dedicated deep-tech seed vehicle, is designed to back B2B startups at the earliest stages of company formation, writing tickets as small as €300,000. The strategy focuses on three broad technology pillars: computing (including generative AI, quantum, and cybersecurity), future of industry (energy, climate technology, and advanced materials), and life sciences."

"The distinctive feature of DTS3, as with its predecessors, is its deep integration with European academic and scientific institutions. These partnerships give Elaia privileged access to spinouts and founding teams before they reach the open market. That pipeline has produced notable results including Aqemia, Alice & Bob, and Mablink Bioscience."

Elaia, a Paris-based venture capital firm backed by Bpifrance and Université PSL, successfully closed its DTS3 deep-tech seed fund at €134 million, surpassing its initial €120 million goal by 12 percent. The fund targets B2B startups in early formation stages across three technology pillars: computing (including generative AI, quantum, and cybersecurity), future of industry (energy, climate technology, advanced materials), and life sciences. Elaia plans approximately 40 initial investments with follow-on funding for 25-30 promising companies. The fund's distinctive feature is its deep integration with European academic institutions, particularly Université PSL, providing privileged access to research-born spinouts and founding teams before market entry. This model has produced successful portfolio companies including Aqemia, Alice & Bob, and Mablink Bioscience.

Read at TNW | Deep-Tech